AI assistant
INOVIO PHARMACEUTICALS, INC. — Director's Dealing 2021
Feb 26, 2021
34008_dirs_2021-02-26_ab74ffe3-a42a-4d35-8c67-562054ca29c7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INOVIO PHARMACEUTICALS, INC. (INO)
CIK: 0001055726
Period of Report: 2021-02-26
Reporting Person: KIES PETER (CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-26 | Common Stock Option | $11.1 | A | 104833 | Acquired | 2031-02-26 | Common Stock (104833.0) | Direct |
| 2021-02-26 | Restricted Stock Unit | $ | A | 67633 | Acquired | Common Stock (67633.0) | Direct |
Footnotes
F1: The vesting schedule for the 104,833 options is as follows: 26,208 shares vested on February 26, 2021; 26,208 shares will vest on February 26, 2022; 26,208 shares will vest on February 26, 2023; 26,209 shares will vest on February 26, 2024.
F2: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 67,633 restricted stock units is as follows: 22,544 shares will vest on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,545 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.